US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Articles published by Biotech Insider

News headline image
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
From Biotech Insider
Via GlobeNewswire
Tickers AVAI SANA VRTX
News headline image
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
From Biotech Insider
Via GlobeNewswire
Tickers AXGN CNXU KRYS NVST VCEL
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
From Biotech Insider
Via GlobeNewswire
Tickers ABBV CNXU ESTA GDERF LLY
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
From Biotech Insider
Via GlobeNewswire
Tickers ABBV CNXU ESTA GALDY INMD
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
Tickers CNXU IART MDXG ORGO VCEL
News headline image
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
From Biotech Insider
Via GlobeNewswire
Tickers FATE GTBP IBRX IOVA NKTX
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
From Biotech Insider
Via GlobeNewswire
Tickers CNXU ESTA INMD PCRX TELA